Skip to main content
. Author manuscript; available in PMC: 2020 Oct 13.
Published in final edited form as: Leukemia. 2018 Jan 30;32(10):2203–2210. doi: 10.1038/s41375-018-0027-y

Table 4.

Standardised incidence ratio (SIR) in all MPN patients compared to the general population. MPN=myeloproliferative neoplasm, CI=confidence interval

Type of
cancer
SIR 95 %CI
All non hematologic 1.4 1.3 - 1.5
Non-melanoma skin cancer 3.3 2.9 - 3.8
Brain 2.1 1.5 - 2.8
Kidney 2 1.5 - 2.7
Endocrine organs 2 1.4 - 2.9
Malignant melanoma 1.9 1.4 - 2.7
Pancreas 1.3 0.9 - 1.9
Lung 1.3 1.1 - 1.6
Head and neck 1.4 1.0 - 2.0
Esophagus and stomach 1.4 1.0 - 1.8
Breast 1 0.8 - 1.2
Prostate 1.1 0.96 - 1.3
Liver and gallbladder 1.2 0.9 - 1.8
Colon, rectum, and anus 1 0.8 - 1.2
Female genital organs 1.4 1.1 - 1.7
Urinary tract excluding kidney 0.9 0.7 - 1.2
Acute myeloid leukemia 33.9 30.1 - 38.1
Lymphoma 2.1 1.7 - 2.6
Multiple myeloma 1.2 0.7 - 1.9